Organoids are three-dimensional miniature organs grown in vitro from stem cells, replicating the structural and functional complexity of actual tissues. These tiny, self-organizing structures have gained prominence in biomedical research due to their potential to mimic the intricacies of human organs, offering a more accurate representation than traditional cell cultures. Organoids have been developed for various organs, including the brain, liver, kidney, and intestine, enabling researchers to study organ development, disease mechanisms, and drug responses. Their ability to recapitulate organ-specific functions makes them invaluable for personalized medicine and drug testing, as well as for understanding diseases like cancer. Organoids have also been utilized in regenerative medicine, holding promise for tissue repair and transplantation. Their applications extend to the study of infectious diseases, providing a platform for investigating host-pathogen interactions. Despite their tremendous potential, challenges such as standardization, scalability, and vascularization remain, and ongoing research aims to address these issues to unlock the full potential of organoids in advancing medical knowledge and therapeutic development.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy